Pacira Pharmaceuticals Inc. (PCRX: Quote) announced after the bell Tuesday that it proposes to offer $100 million of aggregate principal amount of its convertible senior notes due 2019. The stock is now down 0.60 on 64K shares.Pacira Pharmaceuticals posted modest gains around midday Tuesday and finished up by 0.37 at $18.95.
Click here to receive FREE breaking news email alerts for Pacira Pharmaceuticals, Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: editorial@rttnews.comBusiness News